Prostate-specific Membrane Antigen Imaging in Clinical Guidelines: European Association of Urology, National Comprehensive Cancer Network, and Beyond.
作者： Francesco Montorsi , Alberto Briganti , Giorgio Gandaglia , Vito Cucchiara , Nicola Fossati
DOI: 10.1016/J.EUF.2020.12.014
关键词: Prostate cancer 、 Cancer 、 Membrane antigen 、 Glutamate carboxypeptidase II 、 Computed tomography 、 Oncology 、 Medicine 、 Internal medicine 、 Biochemical recurrence 、 Antigen 、 Positron emission tomography
摘要: Prostate-specific membrane antigen (PSMA) imaging is characterized by superior accuracy compared to conventional for identification of nodal and distant metastases in prostate cancer. The majority international clinical guidelines recommend PSMA positron emission tomography/computed tomography patients experiencing biochemical recurrence, even at low prostate-specific values, identify candidates salvage therapies. However, its use primary staging still not recommended.
sci-hub.st 参考文章(23)
Alberto Briganti, Robert Jeffrey Karnes, Giorgio Gandaglia, Martin Spahn, Paolo Gontero, Lorenzo Tosco, Burkhard Kneitz, Felix K.H. Chun, Emanuele Zaffuto, Maxine Sun, Markus Graefen, Giansilvio Marchioro, Detlef Frohneberg, Simone Giona, Pierre I. Karakiewicz, Hein Van Poppel, Francesco Montorsi, Steven Joniau, Natural history of surgically treated high-risk prostate cancer. Urologic Oncology-seminars and Original Investigations. ,vol. 33, pp. 1- 3 ,(2015) , 10.1016/J.UROLONC.2014.11.018
Alberto Briganti, Firas Abdollah, Alessandro Nini, Nazareno Suardi, Andrea Gallina, Umberto Capitanio, Marco Bianchi, Manuela Tutolo, Niccolò Maria Passoni, Andrea Salonia, Renzo Colombo, Massimo Freschi, Patrizio Rigatti, Francesco Montorsi, Performance Characteristics of Computed Tomography in Detecting Lymph Node Metastases in Contemporary Patients with Prostate Cancer Treated with Extended Pelvic Lymph Node Dissection European Urology. ,vol. 61, pp. 1132- 1138 ,(2012) , 10.1016/J.EURURO.2011.11.008
Gordon H Guyatt, Andrew D Oxman, Gunn E Vist, Regina Kunz, Yngve Falck-Ytter, Pablo Alonso-Coello, Holger J Schünemann, None, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ. ,vol. 336, pp. 924- 926 ,(2008) , 10.1136/BMJ.39489.470347.AD
Tobias Maurer, Jürgen E. Gschwend, Isabel Rauscher, Michael Souvatzoglou, Bernhard Haller, Gregor Weirich, Hans-Jürgen Wester, Matthias Heck, Hubert Kübler, Ambros J. Beer, Markus Schwaiger, Matthias Eiber, Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer The Journal of Urology. ,vol. 195, pp. 1436- 1443 ,(2016) , 10.1016/J.JURO.2015.12.025
Nicholas D James, Johann S de Bono, Melissa R Spears, Noel W Clarke, Malcolm D Mason, David P Dearnaley, Alastair WS Ritchie, Claire L Amos, Clare Gilson, Rob J Jones, David Matheson, Robin Millman, Gerhardt Attard, Simon Chowdhury, William R Cross, Silke Gillessen, Christopher C Parker, J Martin Russell, Dominik R Berthold, Chris Brawley, Fawzi Adab, San Aung, Alison J Birtle, Jo Bowen, Susannah Brock, Prabir Chakraborti, Catherine Ferguson, Joanna Gale, Emma Gray, Mohan Hingorani, Peter J Hoskin, Jason F Lester, Zafar I Malik, Fiona McKinna, Neil McPhail, Julian Money-Kyrle, Joe O’Sullivan, Omi Parikh, Andrew Protheroe, Angus Robinson, Narayanan N Srihari, Carys Thomas, John Wagstaff, James Wylie, Anjali Zarkar, Mahesh KB Parmar, Matthew R Sydes, None, Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy The New England Journal of Medicine. ,vol. 377, pp. 338- 351 ,(2017) , 10.1056/NEJMOA1702900
Piet Ost, Dries Reynders, Karel Decaestecker, Valérie Fonteyne, Nicolaas Lumen, Aurélie De Bruycker, Bieke Lambert, Louke Delrue, Renée Bultijnck, Tom Claeys, Els Goetghebeur, Geert Villeirs, Kathia De Man, Filip Ameye, Ignace Billiet, Steven Joniau, Friedl Vanhaverbeke, Gert De Meerleer, Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial Journal of Clinical Oncology. ,vol. 36, pp. 446- 453 ,(2017) , 10.1200/JCO.2017.75.4853
Sangwon Han, Sungmin Woo, Yeon Joo Kim, Chong Hyun Suh, Impact of 68Ga-PSMA PET on the Management of Patients with Prostate Cancer: A Systematic Review and Meta-analysis. European Urology. ,vol. 74, pp. 179- 190 ,(2018) , 10.1016/J.EURURO.2018.03.030
Andrew Kneebone, George Hruby, Hannah Ainsworth, Keelan Byrne, Chris Brown, Linxin Guo, Alexander Guminski, Thomas Eade, Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography European Urology Oncology. ,vol. 1, pp. 531- 537 ,(2018) , 10.1016/J.EUO.2018.04.017
Pieter J.L. De Visschere, Chloë Standaert, Jurgen J. Fütterer, Geert M. Villeirs, Valeria Panebianco, Jochen Walz, Tobias Maurer, Boris A. Hadaschik, Frédéric E. Lecouvet, Gianluca Giannarini, Stefano Fanti, A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer European Urology Oncology. ,vol. 2, pp. 47- 76 ,(2019) , 10.1016/J.EUO.2018.09.010
Thomas A. Hope, Jeremy Z. Goodman, Isabel E. Allen, Jeremie Calais, Wolfgang P. Fendler, Peter R. Carroll, Metaanalysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology The Journal of Nuclear Medicine. ,vol. 60, pp. 786- 793 ,(2019) , 10.2967/JNUMED.118.219501